TERUMO CORPORATION Mediaroom - PR Newswire APAC

Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance

* OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant po...

2025-10-24 20:00 1085

The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies

— Second U.S. site to deploy the Reveos™ system, boosting platelet supply and reducing waste LAKEW...

2025-10-22 22:39 1305

Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System

– Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent fo...

2025-05-28 01:40 1985

Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer

Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terum...

2025-04-17 03:00 2520

Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US

– Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow...

2025-04-17 01:10 2860

Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care

– Collaboration combines Terumo's ePRISM™ precision medicine software platform withMedis' QFR® tech...

2024-12-10 21:00 1737

Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter

– Provides interventionalists with optimal product choices for more complex radial-to-peripheral pr...

2024-12-03 21:00 1592

Terumo Establishes Corporate Venture Capital "Terumo Ventures"

TOKYO, Aug. 6, 2024 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has esta...

2024-08-06 09:00 3294

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

The latest innovation is anticipated to increase collection volume without increasing collection ti...

2024-05-09 20:00 2121

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Reveos is positioned to help U.S. blood centers supplement the platelet supply, reduce labor and co...

2023-08-01 20:30 2027

Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA

IMUGARD to Help Strained U.S. Platelet Supply Meet Growing Need LAKEWOOD, Colo., Feb. 16, 2023 /PRN...

2023-02-17 03:48 2463

Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography

– Researchers used Terumo Health Outcomes' ePRISM® software to calculate safe contrast volume targ...

2022-11-01 20:00 1926

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Adjunctive use of Blood Glucose Meter Principally Not Required TOKYO, May 16, 2022 /PRNewswire/ -- ...

2022-05-16 15:19 4490

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing

A Technology Integration for MEDISAFE WITHTM Insulin Patch Pump Patients to Upload Data Anytime Any...

2022-03-30 15:00 5147

Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing

Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture

TOKYO, Mar. 1, 2022 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has esta...

2022-03-01 09:00 2464

Terumo and Corazon Sign Collaboration and Co-Marketing Agreement

SOMERSET, N.J., Feb. 25, 2022 /PRNewswire/ -- Terumo Health Outcomes, a division of Terumo Medical ...

2022-02-25 22:00 3980

Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A

SOMERSET, N.J., Jan. 11, 2022 /PRNewswire/ -- Terumo Medical Corporation (TMC) applauds the publica...

2022-01-12 03:40 2538

Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings

TOKYO and PARIS, Nov. 17, 2021 /PRNewswire/ -- Terumo Corporation, a global leader in medical techn...

2021-11-17 16:00 2567

Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe

* The therapy aims to re-energize a patient's immune system to fight cancer tumors * Initial co...

2021-11-17 00:00 1939

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare

TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical ...

2021-09-17 15:30 3630

Latest News